IL17A and acute myeloid leukemia: The IL-17 and IL-21 serum concentrations showed statistically significant higher levels in acute leukemia patients compared to healthy volunteers (P < 0.0001 for IL-17 and IL-21, respectively, for both ALL and AML) (Table 2).